These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25703356)

  • 21. Ethyl cellulose nanoparticles: clarithomycin encapsulation and eradication of H. pylori.
    Pan-In P; Banlunara W; Chaichanawongsaroj N; Wanichwecharungruang S
    Carbohydr Polym; 2014 Aug; 109():22-7. PubMed ID: 24815396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The present status and problems of Helicobacter pylori first-line eradication therapy].
    Tokunaga K; Tanaka A; Sugano H; Takahashi S
    Nihon Rinsho; 2009 Dec; 67(12):2291-6. PubMed ID: 19999114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.
    Park CS; Lee SM; Park CH; Koh HR; Jun CH; Park SY; Lee WS; Joo YE; Kim HS; Choi SK; Rew JS
    Am J Gastroenterol; 2014 Oct; 109(10):1595-602. PubMed ID: 25091062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
    Sasaki M; Mizoshita T; Mizushima T; Inoue H; Kamiya T; Kataoka H; Ogaswara N; Wada T; Kubota E; Mori Y; Shimura T; Hirata H; Ando K; Okamoto Y; Ohara H; Nakao H; Joh T
    J Antimicrob Chemother; 2007 Nov; 60(5):1060-3. PubMed ID: 17827146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients.
    Demir M; Gokturk HS; Ozturk NA; Arslan H; Serin E; Yilmaz U
    South Med J; 2009 Nov; 102(11):1116-20. PubMed ID: 19864973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus.
    Adebisi AO; Conway BR
    Int J Pharm; 2014 Aug; 470(1-2):28-40. PubMed ID: 24792977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
    Liu Q; Qi D; Kang J; Jin Y; Liu W; Gao W; Hou P; Lu J
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):221-5. PubMed ID: 25629566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Floating-mucoadhesive beads of clarithromycin for the treatment of Helicobacter pylori infection.
    Gattani SG; Savaliya PJ; Belgamwar VS
    Chem Pharm Bull (Tokyo); 2010 Jun; 58(6):782-7. PubMed ID: 20522987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults.
    Lee JH; Shin JH; Roe IH; Sohn SG; Lee JH; Kang GH; Lee HK; Jeong BC; Lee SH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1600-3. PubMed ID: 15793150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine granules showing sustained drug release prepared by high-shear melt granulation using triglycerin full behenate and milled microcrystalline cellulose.
    Aoki H; Iwao Y; Uchimoto T; Noguchi S; Kajihara R; Takahashi K; Ishida M; Terada Y; Suzuki Y; Itai S
    Int J Pharm; 2015 Jan; 478(2):530-9. PubMed ID: 25434591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation and evaluation of gastroretentive dosage forms of Clarithromycin.
    Nama M; Gonugunta CS; Reddy Veerareddy P
    AAPS PharmSciTech; 2008; 9(1):231-7. PubMed ID: 18446486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The cause of failure of eradication treatment of Helicobacter pylori].
    Chen G; Takeuchi Y; Kikuchi R; Arai D; Fukuchi K; Gomi K
    Rinsho Byori; 2005 Aug; 53(8):692-7. PubMed ID: 16190353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
    Gisbert JP; Mur M; Boixeda D; Ceña G; Martín de Argila C; Alvarez Baleriola I; Abraira V; García Plaza A
    Med Clin (Barc); 1997 Apr; 108(14):524-9. PubMed ID: 9190436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
    Hoshiya S; Watanabe K; Tokunaga K; Tanaka A; Ninomiya H; Shingaki M; Itoh T; Saito S; Ishida H; Takahashi S
    J Gastroenterol; 2000; 35(1):10-4. PubMed ID: 10632534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental design and optimization of a novel dual-release drug delivery system with therapeutic potential against infection with Helicobacter pylori.
    Arrua EC; Sanchez SV; Trincado V; Hidalgo A; Quest AFG; Morales JO
    Colloids Surf B Biointerfaces; 2022 May; 213():112403. PubMed ID: 35219219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of packed therapy with three drugs in Helicobacter pylori eradication in Japan.
    Sasaki M; Ogasawara N; Utsumi K; Kamiya T; Kataoka H; Tanida S; Mizoshita T; Shimura T; Hirata Y; Kasugai K; Joh T
    Methods Find Exp Clin Pharmacol; 2010 May; 32(4):243-6. PubMed ID: 20508872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.